Mazor Robotics Ltd., an Israeli firm that develops technology to help surgeons more accurately and securely perform spinal surgery, said Wednesday it has received clearance from the US Food & Drug Administration for software to help surgeons correct spinal deformities.
The Mazor X Align software is the latest module to be added onto Mazor’s existing suite of software, which includes image processing and computerized anatomy recognition that enable preoperative planning. It is designed to help surgeons better plan procedures when correcting spinal deformities and spinal alignment.
The new software allows surgeons to create a three-dimensional spinal alignment plan that is specific to each patient. The 3D plan simulates the entire spine, allowing surgeons to estimate, prior to an operation, what the impact of a planned surgical correction will be on the patient’s posture after the operation, taking into consideration segmental range-of-motion and final alignment parameters.
Shares of Mazor Robotics, a Caesarea-based firm, advanced 6.1 percent to NIS 54.28 at 12:44 p.m. in Tel Aviv. The shares are traded on the Nasdaq exchange as well.
Mazor X Align will be released to a selection of Mazor customers in early May, the company said in a statement. This early release will be followed by a widespread release during the second half of 2017.
“We are dedicated to pushing the envelope bringing to the market advanced products and applications in order to benefit an increasing number of patients suffering from difficult conditions and supporting the medical professionals serving them,” Ori Hadomi, CEO of Mazor Robotics, said.